Registration successful
Account activated – pending validation.
Your account has been activated successfully, but we still need to validate you as a healthcare professional. We’ll send you an email with the result of the validation process in the next [five] days.
In the meantime, you can enjoy access to all the latest news, events and resources on our website
Our vaccines portfolio
Bexsero
Meningococcal group B vaccines (rDNA, component, adsorbed)
Boostrix
Diphtheria, tetanus and pertussis
(acellular, component) vaccine
(adsorbed, reduced antigen(s) content)
Engerix B 20mcg (Adult)
Hepatitis B (rDNA) vaccine (adsorbed) (HBV)
Fendrix
Hepatitis B (rDNA) vaccine (adjuvanted, adsorbed)
Havrix Monodose
Hepatitis A vaccine
(inactivated, adsorbed)
Havrix Junior Monodose
Hepatitis A vaccine
(inactivated, adsorbed)
Hiberix
Haemophilus Type b (Hib) vaccine
Infanrix Hexa
Diphtheria (D), tetanus (T),
pertussis (acellular, component) (Pa), hepatitis B (rDNA) (HBV), poliomyelitis (inactivated) (IPV) and Haemophilus influenzae type b (Hib) conjugate vaccine (adsorbed)
Menjugate
Meningococcal group C conjugate vaccine
Priorix
Measles, Mumps and Rubella vaccine (live)
rotavirus vaccine, live
Herpes zoster vaccine (recombinant, adjuvanted)
Twinrix (Adult)
Hepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed)
Adverse events should be reported directly to the Health Products Regulatory Authority (HPRA) on their website: www.hpra.ie. Adverse events should also be reported to GlaxoSmithKline on 1800 244 255.
Bexsero, Boostrix, Engerix B, Fendrix, Havrix, Hiberix, Infanrix Hexa, Menitorix, Menjugate, Priorix, Rotarix, Shingrix and Twinrix are registered trademarks of the GlaxoSmithKline Group of Companies.
